|
시장보고서
상품코드
1562262
유럽의 트랜스페션 시약 및 기기 시장 예측(-2030년) : 지역별 분석 - 제품, 방법, 용도, 최종사용자별Europe Transfection Reagents and Equipment Market Forecast to 2030 - Regional Analysis - by Product, Method, Application, and End User |
||||||
유럽의 트랜스페션 시약 및 장비 시장은 2022년에 3억 604만 달러로 평가되며, 2030년에는 5억 5,546만 달러에 달할 것으로 예상되며, 2022년부터 2030년까지 7.7%의 CAGR을 기록할 것으로 추정됩니다.
기업들의 전략적 노력이 유럽 트랜스페션 시약 및 장비 시장을 주도
전염은 아데노 바이러스, 아데노 동반 바이러스, 렌치 바이러스를 포함한 바이러스 벡터를 개발하는 전체 프로세스에서 복잡한 단계입니다. 제조 공정이 확장됨에 따라 일시적인 주입도 확장되어야 합니다. 공정 장비 공급업체, 의약품 개발자 및 원료 공급업체는 바이러스 벡터 제조 공정의 신속한 개발 및 확장을 위해 비용 효율적이고 실용적이며 플랫폼화할 수 있는 솔루션을 개발하기 위해 공동 연구에 집중하고 있습니다. 소규모의 경우, 계획된 재료의 양과 이송 및 혼합 시간에 따라 여러 개의 플라스미드로 세포에 세포를 주입하는 것이 가능합니다. 스케일업에는 세포 주입 단계를 산업화할 수 있는 경험이 필요합니다. 그러나 공정을 더 큰 수준으로 확장하는 데 필요한 세포배양 배지 및 주입 시약의 양은 현실적이지 않을 수 있으며, 이는 최적화의 필요성을 강조합니다. 그럼에도 불구하고 최근 바이러스 벡터에 대한 수요가 급증함에 따라 생산 규모의 확대는 최근 몇 년 동안 보편화되고 있습니다. 대규모 트랜스페션 공정과 관련된 수많은 도전과제가 있기 때문에 생산량을 늘리기 위한 최선의 접근법은 공정의 규모를 늘리는 것이 아니라 공정을 축소하는 것입니다. 이러한 하향식 접근 방식을 통해 산업적 수준에서 공정에 영향을 미치는 조건(예: 트랜스페션 복합 용액의 양 등)을 명확하게 파악할 수 있습니다. 이 접근 방식은 또한 프로세스 최적화 및 의사결정을 용이하게 합니다. 이러한 접근 방식을 통해 소규모 트랜스페션 공정을 강화하는 것은 유럽 트랜스페션 시약 및 장비 시장의 성장 기회로 작용할 수 있습니다.
유럽의 트랜스페션 시약 및 장비 시장 개요
유럽 지역은 영국, 독일, 프랑스, 스페인, 이탈리아, 기타 유럽으로 구분되며, 2022년 영국이 가장 큰 시장 점유율을 차지했습니다. 제약 산업의 성장은 영국에서 진행되는 양질의 연구 개발과 광범위하고 활발한 의료 지식 기반에 의해 결정됩니다. 영국은 첨단 치료제의 연구 개발, 제조, 임상 채택 및 상환에 있어 세계 최고의 생태계 중 하나입니다. 현재 영국에서는 85개 이상의 임상시험이 진행 중이며, 70개의 CGT 기업이 잠재적 치료법을 개발하기 위해 노력하고 있습니다. Catapult는 영국 CGT 생태계에 크게 기여하는 선도 기업이며, 시약 및 장치 제조 공정 개발에 종사하는 영국 내 상위 5개 기업 중 하나입니다. 이 회사는 최소한의 개입으로 변화하는 환경과 프로세스 요구 사항에 자동으로 적응할 수 있는 보다 스마트한 자동 CGT 제조 프로세스 개발에 주력하고 있습니다. 따라서 영국에 기반을 둔 기업들의 생산성 향상과 최종 제품 비용 절감을 위한 노력은 영국 세포 및 유전자 치료 시장의 성장을 촉진하는 주요 요인으로 작용하고 있습니다. 또한, 영국은 연구에 대한 지속적이고 집중적인 투자로 유럽 세포 및 유전자 치료 시장에서 확고한 위치를 차지하고 있으며, 이는 시장 성장에 더욱 도움이 되고 있습니다.
또한 프랑스에는 사노피(Sanofi S.A.), 입센(Ipsen), 피에르 파브르(Pierre Fabre), HRA 파마(HRA Pharma), TxCell(Sangamo Therapeutics, Inc.)과 같은 대형 바이오제약 및 제약기업들이 진출해 있습니다. 이들 기업은 백신, 항체 등의 개발에 참여하고 있으며, 제품의 동결건조가 필요하기 때문에 트랜스펙션 시약 및 장비의 수요에 기여하고 있습니다.
유럽의 트랜스페션 시약 및 장비 시장 매출 및 2030년까지의 예측(금액)
유럽의 트랜스페션 시약 및 장비 시장 세분화
유럽의 트랜스페션 시약 및 장비 시장은 제품, 방법, 용도, 최종사용자, 국가별로 세분화되어 있습니다.
제품별로 보면 유럽 트랜스페션 시약 및 장비 시장은 시약과 장비로 나뉩니다. 시약 부문은 2022년 큰 비중을 차지했습니다.
방법별로는 유럽 트랜스페션 시약 및 장비 시장은 바이러스 방법, 비바이러스 방법, 하이브리드 방법으로 구분되며, 2022년에는 비바이러스 방법이 가장 큰 점유율을 차지했습니다. 바이러스 방법은 레트로바이러스, 아데노바이러스, 아데노 관련 바이러스, 헤르페스 바이러스로 분류됩니다. 비바이러스성 부문은 물리적/기계적 방법과 화학적 방법으로 나뉩니다. 또한, 물리적/기계적 방법은 일렉트로포레이션법, 마이크로 인젝션법, 바이오리스틱법, 레이저법, 마그네토펙션법, 소노포레이션법으로 세분화됩니다. 또한, 화학적 방법은 리포좀 기반/고지질 기반과 비리포좀/고지질 기반으로 세분화됩니다.
용도별로 유럽 트랜스페션 시약 및 기기 시장은 생물의학 연구, 단백질 생산, 치료 전달로 구분됩니다. 바이오 의학 연구 부문이 2022년 가장 큰 점유율을 차지했습니다.
최종사용자에 따라 유럽 이식 시약 및 장비 시장은 학술 및 연구 기관과 제약 및 생명공학 기업으로 양분되며, 2022년에는 학술 및 연구 기관 부문이 큰 비중을 차지했습니다.
국가별로 보면 유럽 이식 시약 및 장비 시장은 독일, 프랑스, 영국, 이탈리아, 스페인, 기타 유럽으로 분류됩니다. 영국은 2022년 유럽 이식 시약 및 장비 시장을 독점했습니다.
Fisher Scientific Inc, Promega Corp, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, Virus Bio LLC, QIAGEN NV, Merck KGaA, Lonza Group AG, MaxCyte Inc, Polyplus-Transfection SA, MaxCyte Inc, Polyplus-Transfection SA는 유럽 트랜스페션 시약 및 장비 시장에서 사업을 전개하는 주요 기업입니다.
목차
제1장 소개
제2장 주요 요약
- 주요 인사이트
제3장 조사 방법
- 조사 범위
- 2차 조사
- 1차 조사
제4장 유럽의 트랜스펙션 시약 및 장비 시장 - 주요 시장 역학
- 유럽의 트랜스펙션 시약 및 장비 시장 : 주요 시장 역학
- 시장 성장 촉진요인
- 세포 치료와 유전자 치료의 인기 상승
- 암의 경제적 부담 증대
- 시장 성장 억제요인
- 기기 및 소모품의 고비용
- 시장 기회
- 소규모 프로세스에서 대규모 프로세스로의 확대
- 향후 동향
- 기업의 전략적 대처
- 성장 촉진요인과 억제요인의 영향
제5장 트랜스펙션 시약 및 장비 시장 : 유럽 시장 분석
- 유럽의 트랜스펙션 시약 및 장비 시장 매출, 2022-2030년
- 유럽의 트랜스펙션 시약 및 장비 시장 예측 분석
제6장 유럽의 트랜스펙션 시약 및 장비 시장 분석 : 제품별
- 시약
- 장비
제7장 유럽의 트랜스펙션 시약 및 장비 시장 분석 : 모달리티별
- 바이러스
- 비바이러스
- 하이브리드
제8장 유럽의 트랜스펙션 시약 및 장비 시장 분석 : 용도별
- 바이오메디컬 연구
- 단백질 생산
- 치료 딜리버리
제9장 유럽의 트랜스펙션 시약 및 장비 시장 분석 : 최종사용자별
- 학술·연구기관
- 제약·바이오테크놀러지 기업
제10장 유럽의 트랜스펙션 시약 및 장비 시장 : 국가별 분석
- 유럽
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 기타 유럽
제11장 트랜스펙션 시약 및 장비 시장 : 업계 상황
- 트랜스펙션 시약 및 장비 시장의 성장 전략, 2020-2023년
- 무기적 성장 전략
- 유기적 성장 전략
제12장 기업 개요
- Thermo Fisher Scientific Inc
- Promega Corp
- F. Hoffmann-La Roche Ltd
- Bio-Rad Laboratories Inc
- Mirus Bio LLC
- QIAGEN NV
- Merck KGaA
- Lonza Group AG
- MaxCyte Inc
- Polyplus-Transfection SA
제13장 부록
ksm 24.10.10The Europe transfection reagents and equipment market was valued at US$ 306.04 million in 2022 and is expected to reach US$ 555.46 million by 2030; it is estimated to register at a CAGR of 7.7% from 2022 to 2030.
Strategic Initiatives by Companies Drive Europe Transfection Reagents and Equipment Market
Transfection is the complex step in the overall process of developing a viral vector, which includes adenovirus, adeno-associated virus, and lentivirus. As the manufacturing processes are scaled up, transient transfection must also be ramped up. Process equipment vendors, drug developers, and raw material suppliers are focusing on collaborations to develop cost-effective, practical, and platformizable solutions for the rapid development and scaling up of viral vector manufacturing processes. On small scales, with planned material volumes and transfer & mixing times, transfecting cells with multiple plasmids becomes feasible. Scaling up requires experience in industrializing the transfection step since most companies only have transfection experience at the lab level. However, the volume of cell-culture media and transfection reagents required for scaling up the process to a larger level can be impractical, which emphasizes the need for optimization. Nonetheless, broadening the scale of production has become common in recent years with the surging demand for viral vectors. With numerous challenges associated with large-scale transfection processes, the best approach to increase production is by reducing the process rather than scaling up the process. This top-down approach allows clear identification of the conditions that will impact the process at the industrial level such as the volume of transfection complex solution. This approach also facilitates process optimization and decision-making. The development of such approaches to ramp up the small-scale transfection processes acts as an opportunity for the growth of the Europe transfection reagents and equipment market.
Europe Transfection Reagents and Equipment Market Overview
Europe region segmented into UK, Germany, France, Spain, Italy, and Rest of Europe. United Kingdom holds the largest market share in the year 2022. The growth of the pharmaceutical industry is determined by the high-quality research and development ongoing in the country, and extensive and flourishing healthcare knowledge base. The UK is one of the world's best ecosystems for research, development, manufacturing, clinical adoption, and reimbursement of advanced therapeutics. Currently, over 85 clinical trials are ongoing in the UK, and 70 CGT companies are striving to develop potentially curative therapies. Catapult is a top company that has been contributing significantly to the CGT ecosystem in the UK; it stands as one of the top five companies involved in developing manufacturing processes of reagents and devices in the country. The company is focused on developing smarter automated CGT manufacturing processes that can automatically adapt to changing environments and process requirements with minimal intervention. Therefore, efforts made by UK-based companies to enhance productivity and reduce final product costs are the major factors driving the growth of the cell and gene therapy market in the UK. Moreover, the UK holds a strong position in the cell and gene therapy market in Europe owing to sustained and targeted investment in research, which further benefits the market.
Moreover, France has the presence of biopharmaceutical and pharmaceutical giants such as Sanofi S.A., Ipsen, Pierre Fabre, HRA Pharma, and TxCell (Sangamo Therapeutics, Inc.). These companies are involved in the development of vaccines and antibodies, among others, which require freeze-drying for their products, which contributes to the demand for transfection reagents and equipment.
Europe Transfection Reagents and Equipment Market Revenue and Forecast to 2030 (US$ Million)
Europe Transfection Reagents and Equipment Market Segmentation
The Europe transfection reagents and equipment market is segmented based on product, method, application, end user, and country.
Based on product, the Europe transfection reagents and equipment market is bifurcated into reagents and instruments. The reagents segment held a larger share in 2022.
In terms of method, the Europe transfection reagents and equipment market is segmented into viral methods, non-viral methods, and hybrid methods. The non-viral methods segment held the largest share in 2022. The viral segment is subcategorized into retrovirus, adenovirus, adeno associated virus, and herpes virus. The non-viral segment is bifurcated into physical/mechanical method and chemical method. Further, the physical/mechanical method segment is subcategorized into electroporation, microinjection, biolistic method, laser method, magnetofection, and sonoporation. Also, the chemical method segment is subcategorized into liposomal based/high lipid and non-liposomal/high lipid based.
By application, the Europe transfection reagents and equipment market is segmented into biomedical research, protein production, and therapeutic delivery. The biomedical research segment held the largest share in 2022.
Based on end user, the Europe transfection reagents and equipment market is bifurcated into academics & research institutes and pharmaceutical & biotechnology companies. The academics & research institutes segment held a larger share in 2022.
Based on country, the Europe transfection reagents and equipment market is categorized into Germany, France, the UK, Italy, Spain, and the Rest of Europe. The UK dominated the Europe transfection reagents and equipment market in 2022.
Fisher Scientific Inc, Promega Corp, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, Mirus Bio LLC, QIAGEN NV, Merck KGaA, Lonza Group AG, MaxCyte Inc, and Polyplus-Transfection SA are some of the leading companies operating in the Europe transfection reagents and equipment market.
Table Of Contents
1. Introduction
- 1.1 The Insight Partners Research Report Guidance
- 1.2 Market Segmentation
2. Executive Summary
- 2.1 Key Insights
3. Research Methodology
- 3.1 Coverage
- 3.2 Secondary Research
- 3.3 Primary Research
4. Europe Transfection Reagents and Equipment Market - Key Market Dynamics
- 4.1 Europe Transfection Reagents and Equipment Market - Key Market Dynamics
- 4.2 Market Drivers
- 4.2.1 Increasing Popularity of Cell and Gene Therapy
- 4.2.2 Growing Economic Burden of Cancer
- 4.3 Market Restraints
- 4.3.1 High Cost of Instruments and Consumables
- 4.4 Market Opportunities
- 4.4.1 Ramping Up Small-Scale Processes to Large-Scale Processes
- 4.5 Future Trends
- 4.5.1 Strategic Initiatives by Companies
- 4.6 Impact of Drivers and Restraints:
5. Transfection Reagents and Equipment Market - Europe Market Analysis
- 5.1 Europe Transfection Reagents and Equipment Market Revenue (US$ Million), 2022-2030
- 5.2 Europe Transfection Reagents and Equipment Market Forecast Analysis
6. Europe Transfection Reagents and Equipment Market Analysis - by Product
- 6.1 Reagents
- 6.1.1 Overview
- 6.1.2 Reagents: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
- 6.2 Equipment
- 6.2.1 Overview
- 6.2.2 Equipment: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7. Europe Transfection Reagents and Equipment Market Analysis - by Modality
- 7.1 Viral
- 7.1.1 Overview
- 7.1.2 Viral: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
- 7.1.2.1 Retrovirus: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
- 7.1.2.2 Adenovirus: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
- 7.1.2.3 Adeno-Associated Virus: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
- 7.1.2.4 Herpes Virus: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
- 7.2 Non-Viral
- 7.2.1 Overview
- 7.2.2 Non-Viral: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
- 7.2.2.1 Physical/Mechanical Method: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
- 7.2.2.1.1 Electroporation: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
- 7.2.2.1.2 Microinjection: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
- 7.2.2.1.3 Biolistic Method: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
- 7.2.2.1.4 Laser Method: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
- 7.2.2.1.5 Magnetofection: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
- 7.2.2.1.6 Sonoporation: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
- 7.2.2.2 Chemical Method: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
- 7.2.2.2.1 Liposomal Based/High Lipid: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
- 7.2.2.2.2 Non-Liposomal Based/High Lipid: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
- 7.2.2.1 Physical/Mechanical Method: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3 Hybrid
- 7.3.1 Overview
- 7.3.2 Hybrid: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
8. Europe Transfection Reagents and Equipment Market Analysis - by Application
- 8.1 Biomedical Research
- 8.1.1 Overview
- 8.1.2 Biomedical Research: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
- 8.2 Protein Production
- 8.2.1 Overview
- 8.2.2 Protein Production: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
- 8.3 Therapeutic Delivery
- 8.3.1 Overview
- 8.3.2 Therapeutic Delivery: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
9. Europe Transfection Reagents and Equipment Market Analysis - by End Users
- 9.1 Academic and Research Institutes
- 9.1.1 Overview
- 9.1.2 Academic and Research Institutes: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
- 9.2 Pharmaceutical and Biotechnological Companies
- 9.2.1 Overview
- 9.2.2 Pharmaceutical and Biotechnological Companies: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
10. Europe Transfection Reagents and Equipment Market -Country Analysis
- 10.1 Europe: Transfection Reagents and Equipment Market - Revenue and Forecast Analysis - by Country
- 10.1.1 Europe: Transfection Reagents and Equipment Market - Revenue and Forecast Analysis - by Country
- 10.1.2 United Kingdom: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
- 10.1.2.1 United Kingdom: Transfection Reagents and Equipment Market Breakdown, by Product
- 10.1.2.2 United Kingdom: Transfection Reagents and Equipment Market Breakdown, by Modality
- 10.1.2.2.1 United Kingdom: Transfection Reagents and Equipment Market Breakdown, by Viral
- 10.1.2.2.2 United Kingdom: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
- 10.1.2.2.2.1 United Kingdom: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
- 10.1.2.2.2.2 United Kingdom: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
- 10.1.2.3 United Kingdom: Transfection Reagents and Equipment Market Breakdown, by Application
- 10.1.2.4 United Kingdom: Transfection Reagents and Equipment Market Breakdown, by End Users
- 10.1.3 Germany: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
- 10.1.3.1 Germany: Transfection Reagents and Equipment Market Breakdown, by Product
- 10.1.3.2 Germany: Transfection Reagents and Equipment Market Breakdown, by Modality
- 10.1.3.2.1 Germany: Transfection Reagents and Equipment Market Breakdown, by Viral
- 10.1.3.2.2 Germany: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
- 10.1.3.2.2.1 Germany: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
- 10.1.3.2.2.2 Germany: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
- 10.1.3.3 Germany: Transfection Reagents and Equipment Market Breakdown, by Application
- 10.1.3.4 Germany: Transfection Reagents and Equipment Market Breakdown, by End Users
- 10.1.4 France: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
- 10.1.4.1 France: Transfection Reagents and Equipment Market Breakdown, by Product
- 10.1.4.2 France: Transfection Reagents and Equipment Market Breakdown, by Modality
- 10.1.4.2.1 France: Transfection Reagents and Equipment Market Breakdown, by Viral
- 10.1.4.2.2 France: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
- 10.1.4.2.2.1 France: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
- 10.1.4.2.2.2 France: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
- 10.1.4.3 France: Transfection Reagents and Equipment Market Breakdown, by Application
- 10.1.4.4 France: Transfection Reagents and Equipment Market Breakdown, by End Users
- 10.1.5 Italy: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
- 10.1.5.1 Italy: Transfection Reagents and Equipment Market Breakdown, by Product
- 10.1.5.2 Italy: Transfection Reagents and Equipment Market Breakdown, by Modality
- 10.1.5.2.1 Italy: Transfection Reagents and Equipment Market Breakdown, by Viral
- 10.1.5.2.2 Italy: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
- 10.1.5.2.2.1 Italy: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
- 10.1.5.2.2.2 Italy: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
- 10.1.5.3 Italy: Transfection Reagents and Equipment Market Breakdown, by Application
- 10.1.5.4 Italy: Transfection Reagents and Equipment Market Breakdown, by End Users
- 10.1.6 Spain: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
- 10.1.6.1 Spain: Transfection Reagents and Equipment Market Breakdown, by Product
- 10.1.6.2 Spain: Transfection Reagents and Equipment Market Breakdown, by Modality
- 10.1.6.2.1 Spain: Transfection Reagents and Equipment Market Breakdown, by Viral
- 10.1.6.2.2 Spain: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
- 10.1.6.2.2.1 Spain: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
- 10.1.6.2.2.2 Spain: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
- 10.1.6.3 Spain: Transfection Reagents and Equipment Market Breakdown, by Application
- 10.1.6.4 Spain: Transfection Reagents and Equipment Market Breakdown, by End Users
- 10.1.7 Rest of Europe: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
- 10.1.7.1 Rest of Europe: Transfection Reagents and Equipment Market Breakdown, by Product
- 10.1.7.2 Rest of Europe: Transfection Reagents and Equipment Market Breakdown, by Modality
- 10.1.7.2.1 Rest of Europe: Transfection Reagents and Equipment Market Breakdown, by Viral
- 10.1.7.2.2 Rest of Europe: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
- 10.1.7.2.2.1 Rest of Europe: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
- 10.1.7.2.2.2 Rest of Europe: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
- 10.1.7.3 Rest of Europe: Transfection Reagents and Equipment Market Breakdown, by Application
- 10.1.7.4 Rest of Europe: Transfection Reagents and Equipment Market Breakdown, by End Users
11. Transfection Reagents and Equipment Market -Industry Landscape
- 11.1 Overview
- 11.2 Growth Strategies in The Transfection Reagents and Equipment Market, 2020-2023
- 11.3 Inorganic Growth Strategies
- 11.3.1 Overview
- 11.4 Organic Growth Strategies
- 11.4.1 Overview
12. Company Profiles
- 12.1 Thermo Fisher Scientific Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
- 12.2 Promega Corp
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
- 12.3 F. Hoffmann-La Roche Ltd
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
- 12.4 Bio-Rad Laboratories Inc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
- 12.5 Mirus Bio LLC
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
- 12.6 QIAGEN NV
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
- 12.7 Merck KGaA
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
- 12.8 Lonza Group AG
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
- 12.9 MaxCyte Inc
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
- 12.10 Polyplus-Transfection SA
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments
13. Appendix
- 13.1 About Us
